Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres

被引：1
|
作者：
McCaughan, Georgia J. [1 ,2 ]
Verma, Anvita [2 ,3 ]
Ling, Silvia [2 ,3 ]
Lavee, Orly [1 ]
Moore, John J. [1 ,3 ]
Bryant, Adam [2 ,3 ]
机构：
[1] St Vincents Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[3] Liverpool Hosp, Dept Haematol, Sydney, NSW, Australia
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / 03期
关键词：
INDUCTION THERAPY; DEXAMETHASONE VCD; SUPERIOR; VTD;
D O I：
10.1038/s41409-020-01086-9
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：738 / 740
页数：3
相关论文
共 50 条
  • [31] Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
    Ajay K. Nooka
    Jonathan L. Kaufman
    Cesar Rodriguez
    Andrzej Jakubowiak
    Yvonne Efebera
    Brandi Reeves
    Tanya Wildes
    Sarah A. Holstein
    Larry D. Anderson
    Ashraf Badros
    Leyla Shune
    Ajai Chari
    Huiling Pei
    Annelore Cortoos
    Sharmila Patel
    J. Blake Bartlett
    Jessica Vermeulen
    Thomas S. Lin
    Paul G. Richardson
    Peter Voorhees
    Blood Cancer Journal, 12
  • [32] Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Lenalidomide and Dexamethasone (LD) for the Treatment of Non-Transplant Eligible MM
    Jimenez-Zepeda, Victor
    Belch, Andrew R.
    Sandhu, Irwindeep
    Bahlis, Nizar J.
    Duggan, Peter
    Neri, Paola
    Tay, Jason
    Nikitina, Tatiana
    Hewitt, Joanne
    Venner, Chritopher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E68 - E68
  • [33] Superiority of Triple Combination Bortezomib plus Cyclophosphamide and Dexamethasone (VCD) Versus Thalidomide plus Cyclophosphamide and Dexamethasone (CTD) in Newly Diagnosed Multiple Myeloma Transplant-Eligible Patients
    Crusoe, Edvan De Queiroz
    Higashi, Fabiana
    Martinez, Gracia
    Bittencourt, Rosane
    Maiolino, Angelo
    Sousa, Lais
    Nunes, Renata Ferreira Marques
    Ribeiro, Glaciano
    Nicacio, Jandir
    Zanella, Karla Richter
    Magalhaes, Andre
    Leao, Danielle
    Pinto Neto, Jorge Vaz
    Hallack Neto, Abrahao Elias
    Braga, Walter
    Souza, Emmanuella G.
    Guimaraes, Antonio Julio A. M.
    Durigon, Giovanna Steffenello
    Laks, Dani
    Kutner, Jose Mauro
    Colli, Gilberto
    Santucci, Rodrigo
    Magalhaes, Roberto Jose Pessoa
    Hungria, Vania T. M.
    BLOOD, 2017, 130
  • [34] Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
    Mohty, Mohamad
    Harousseau, Jean-Luc
    HAEMATOLOGICA, 2014, 99 (03) : 408 - 416
  • [35] Consensus statement on the treatment of transplant-eligible patients with newly diagnosed multiple myeloma in New Zealand
    Chien, Nicole
    Romeril, Ken
    Baker, Bart
    Goodman, Hugh
    Chan, Henry
    NEW ZEALAND MEDICAL JOURNAL, 2020, 133 (1527) : 104 - 110
  • [36] Frontline treatment for transplant-eligible multiple myeloma: A 6474 patients network meta-analysis
    Sekine, Leo
    Ziegelmann, Patricia Klarmann
    Manica, Denise
    Pithan, Carolina da Fonte
    Sosnoski, Monalisa
    Morais, Vinicius Daudt
    Falcetta, Frederico Soares
    Ribeiro, Mariana Rangel
    Salazar, Ana Paula
    Ribeiro, Rodrigo Antonini
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (01) : 62 - 74
  • [37] Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients
    Gonzalez-Calle, Veronica
    Slack, Abigail
    Luft, Susan
    Pearce, Kathryn
    Ketterling, Rhett P.
    Jain, Tania
    Chirackal, Sinto Sebastian
    Reeder, Craig B.
    Mikhael, Joseph
    Bergsagel, Leif
    Noel, Pierre
    Mayo, Angela
    Slack, James L.
    Adams, Roberta H.
    Ahmann, Gregory
    Braggio, Esteban
    Stewart, Keith
    Van Wier, Scott
    Fonseca, Rafael
    BLOOD, 2016, 128 (22)
  • [38] Optimal approach to stem cell mobilization in transplant-eligible multiple myeloma patients
    Fitzsimons, Jack
    Hagen, Patrick A.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2024, 10
  • [39] The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients
    McCarthy, Philip L.
    Einsele, Hermann
    Attal, Michel
    Giralt, Sergio
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 55 - 66
  • [40] Evolving strategies in the management of transplant-eligible patients with newly diagnosed multiple myeloma
    Perrot, Aurore
    PRESSE MEDICALE, 2025, 54 (01):
12345